paliperidone

Poland

Drugs containing this active substance

  • DENEPRA

    The medicine is used for the maintenance treatment of schizophrenia symptoms in stable adult patients who have previously been treated with paliperidone or risperidone. It helps to relieve symptoms of the disease and prevent their recurrence.

    Form: suspension for injection prolonged release in prefilled syringe

    Active substance Dosage
    paliperidone 25 mg

    ATC: N05AX13

    Manufacturer: Lek Pharmaceuticals d.d. Pharmascience International Limited

  • The medicine is used for the maintenance treatment of schizophrenia symptoms in stable adult patients who have previously been treated with paliperidone or risperidone. It helps to alleviate disease symptoms and prevent their recurrence.

    Form: suspension for injection prolonged release in prefilled syringe

    Active substance Dosage
    paliperidone 50 mg

    ATC: N05AX13

    Manufacturer: Lek Pharmaceuticals d.d. Pharmascience International Limited

  • The medicine is used for the maintenance treatment of schizophrenia symptoms in stable adult patients who have previously been treated with paliperidone or risperidone. It helps to alleviate disease symptoms and prevent their recurrence.

    Form: suspension for injection prolonged release in prefilled syringe

    Active substance Dosage
    paliperidone 75 mg

    ATC: N05AX13

    Manufacturer: Lek Pharmaceuticals d.d. Pharmascience International Limited

  • The medicine is used for the maintenance treatment of schizophrenia symptoms in stable adult patients who have previously been treated with paliperidone or risperidone. It helps to alleviate disease symptoms and prevent their recurrence.

    Form: suspension for injection prolonged release in prefilled syringe

    Active substance Dosage
    paliperidone 100 mg

    ATC: N05AX13

    Manufacturer: Lek Pharmaceuticals d.d. Pharmascience International Limited

  • The medicine is used for the maintenance treatment of schizophrenia symptoms in stable adult patients who have previously been treated with paliperidone or risperidone. It helps to alleviate symptoms of the disease and prevent their recurrence.

    Form: suspension for injection prolonged release in prefilled syringe

    Active substance Dosage
    paliperidone 150 mg

    ATC: N05AX13

    Manufacturer: Lek Pharmaceuticals d.d. Pharmascience International Limited

  • The medicine is used for the maintenance treatment of schizophrenia symptoms in stable adult patients who have previously been treated with paliperidone or risperidone. It helps to alleviate disease symptoms and prevent their recurrence.

    Form: suspension for injection prolonged release in prefilled syringe

    Active substance Dosage
    paliperidone 100 mg or 150 mg

    ATC: N05AX13

    Manufacturer: Lek Pharmaceuticals d.d. Pharmascience International Limited

  • The medicine is used for the maintenance treatment of schizophrenia symptoms in adult patients who have already been stabilized with paliperidone or risperidone.

    Form: suspension for injection with prolonged release

    Active substance Dosage
    paliperidone 25 mg

    ATC: N05AX13

    Manufacturer: Pharmathen International S.A.

  • The medicine is used for the maintenance treatment of schizophrenia symptoms in adult patients who have been previously stabilized with paliperidone or risperidone.

    Form: suspension for injection with prolonged release

    Active substance Dosage
    paliperidone 50 mg

    ATC: N05AX13

    Manufacturer: Pharmaten International S.A.

  • The medicine is used for the maintenance treatment of schizophrenia symptoms in adult patients who have been previously stabilized with paliperidone or risperidone. It may help alleviate disease symptoms and prevent their recurrence.

    Form: suspension for injection with prolonged release

    Active substance Dosage
    paliperidone 75 mg

    ATC: N05AX13

    Manufacturer: Pharmaten International S.A.

  • The medicine is used for the maintenance treatment of schizophrenia symptoms in adult patients who have been previously stabilized with paliperidone or risperidone.

    Form: suspension for injection with prolonged release

    Active substance Dosage
    paliperidone 100 mg

    ATC: N05AX13

    Manufacturer: Pharmathen International S.A.

  • The medicine is used for the maintenance treatment of schizophrenia symptoms in adult patients who have been previously stabilized with paliperidone or risperidone.

    Form: suspension for injection with prolonged release

    Active substance Dosage
    paliperidone 150 mg

    ATC: N05AX13

    Manufacturer: Pharmaten International S.A.

  • The medicine is used for the maintenance treatment of schizophrenia symptoms in stable adult patients who have previously been treated with paliperidone or risperidone. It helps to alleviate disease symptoms and prevent their recurrence.

    Form: suspension for injection prolonged release in prefilled syringe

    Active substance Dosage
    paliperidone 50 mg

    ATC: N05AX13

    Manufacturer: Adamed Pharma S.A.

  • The medicine is used for the maintenance treatment of schizophrenia symptoms in stable adult patients who have previously been treated with paliperidone or risperidone. It helps to alleviate disease symptoms and prevent their recurrence.

    Form: suspension for injection prolonged release in prefilled syringe

    Active substance Dosage
    paliperidone 75 mg

    ATC: N05AX13

    Manufacturer: Adamed Pharma S.A.

  • The medicine is used for the maintenance treatment of schizophrenia symptoms in stable adult patients who have previously been treated with paliperidone or risperidone. It helps to alleviate disease symptoms and prevent their recurrence.

    Form: suspension for injection prolonged release in prefilled syringe

    Active substance Dosage
    paliperidone 100 mg

    ATC: N05AX13

    Manufacturer: Adamed Pharma S.A.

  • The medicine is used for the maintenance treatment of schizophrenia symptoms in stable adult patients who have previously been treated with paliperidone or risperidone. It helps to alleviate disease symptoms and prevent their recurrence.

    Form: suspension for injection prolonged release in prefilled syringe

    Active substance Dosage
    paliperidone 150 mg

    ATC: N05AX13

    Manufacturer: Adamed Pharma S.A.

  • The medicinal product is used for the maintenance treatment of schizophrenia symptoms in stable adult patients who have previously been treated with paliperidone or risperidone.

    Form: suspension for injection prolonged release in prefilled syringe

    Active substance Dosage
    paliperidone 100 mg or 150 mg

    ATC: N05AX13

    Manufacturer: Adamed Pharma S.A.

  • The medicinal product is used for the maintenance treatment of schizophrenia symptoms in adult patients who have been stabilized with paliperidone or risperidone therapy. It helps to alleviate disease symptoms and prevent their recurrence.

    Form: suspension for injection prolonged release in prefilled syringe

    Active substance Dosage
    paliperidone 150 mg

    ATC: N05AX13

    Manufacturer: Pharmascience International Ltd. Universal Farma, S.L.

  • The medicinal product is used for the maintenance treatment of schizophrenia symptoms in adult patients whose symptoms have been stabilized with paliperidone or risperidone. It helps to alleviate disease symptoms and prevent their recurrence.

    Form: suspension for injection prolonged release in prefilled syringe

    Active substance Dosage
    paliperidone 25 mg

    ATC: N05AX13

    Manufacturer: Pharmascience International Ltd. Universal Farma, S.L.

  • The medicinal product is used for the maintenance treatment of schizophrenia symptoms in adult patients whose symptoms have been stabilized with paliperidone or risperidone. It helps to alleviate disease symptoms and prevent their recurrence.

    Form: suspension for injection prolonged release in prefilled syringe

    Active substance Dosage
    paliperidone 75 mg

    ATC: N05AX13

    Manufacturer: Pharmascience International Ltd. Universal Farma, S.L.

  • The medicine is used for the maintenance treatment of schizophrenia symptoms in adult patients who have already been stabilized with paliperidone or risperidone. It helps to alleviate symptoms of the disease and prevent their recurrence.

    Form: suspension for injection prolonged release in prefilled syringe

    Active substance Dosage
    paliperidone 100 mg

    ATC: N05AX13

    Manufacturer: Pharmascience International Ltd. Universal Farma, S.L.

  • The medicine is used for the maintenance treatment of schizophrenia symptoms in adult patients whose symptoms have been stabilized with paliperidone or risperidone. It helps to alleviate disease symptoms and prevent their recurrence.

    Form: suspension for injection prolonged release in prefilled syringe

    Active substance Dosage
    paliperidone 100 mg or 150 mg

    ATC: N05AX13

    Manufacturer: Pharmascience International Ltd. Universal Farma, S.L.

  • The medicinal product is used for the maintenance treatment of schizophrenia symptoms in adult patients who have already been stabilized with paliperidone or risperidone. It helps to alleviate symptoms of the disease and prevent their recurrence.

    Form: suspension for injection prolonged release in prefilled syringe

    Active substance Dosage
    paliperidone 50 mg

    ATC: N05AX13

    Manufacturer: Pharmascience International Ltd. Universal Farma, S.L.

  • The medicine is used to treat schizophrenia in adults and adolescents (from 15 years of age), as well as to treat schizoaffective disorders in adults. It helps to alleviate the symptoms of the disease and prevent their recurrence.

    Form: tablets, prolonged release

    Active substance Dosage
    paliperidone 3 mg

    ATC: N05AX13

    Manufacturer: Krka, d.d., Novo mesto

  • The medicine is used for the treatment of schizophrenia in adults and adolescents from 15 years of age, as well as for the treatment of schizoaffective disorders in adults. It helps to alleviate symptoms of the disease and prevent their recurrence.

    Form: tablets, prolonged release

    Active substance Dosage
    paliperidone 6 mg

    ATC: N05AX13

    Manufacturer: Krka, d.d., Novo mesto

  • The medicine is used for the treatment of schizophrenia in adults and adolescents from 15 years of age, as well as for the treatment of schizoaffective disorders in adults.

    Form: tablets, prolonged release

    Active substance Dosage
    paliperidone 9 mg

    ATC: N05AX13

    Manufacturer: Krka, d.d., Novo mesto

  • The medicine is used for the maintenance treatment of schizophrenia symptoms in stable adult patients who have previously been treated with paliperidone or risperidone. It helps to alleviate symptoms of the disease and prevent their recurrence.

    Form: suspension for injection prolonged release in prefilled syringe

    Active substance Dosage
    paliperidone 25 mg/0.25 ml

    ATC: N05AX13

    Manufacturer: Pharmascience International Ltd. Universal Farma, S.L.

  • The medicine is used for the maintenance treatment of schizophrenia symptoms in stable adult patients who have previously been treated with paliperidone or risperidone. It helps to alleviate disease symptoms and prevent their recurrence.

    Form: suspension for injection prolonged release in prefilled syringe

    Active substance Dosage
    paliperidone 50 mg/0.5 ml

    ATC: N05AX13

    Manufacturer: Pharmascience International Ltd. Universal Farma, S.L.

  • The medicine is used for the maintenance treatment of schizophrenia symptoms in stable adult patients who have previously been treated with paliperidone or risperidone. It helps to alleviate symptoms of the disease and prevent their recurrence.

    Form: suspension for injection prolonged release in prefilled syringe

    Active substance Dosage
    paliperidone 75 mg/0.75 ml

    ATC: N05AX13

    Manufacturer: Pharmascience International Ltd. Universal Farma, S.L.

  • The medicine is used for the maintenance treatment of schizophrenia symptoms in stable adult patients who have previously been treated with paliperidone or risperidone. It helps to alleviate symptoms of the disease and prevent their recurrence.

    Form: suspension for injection prolonged release in prefilled syringe

    Active substance Dosage
    paliperidone 100 mg/1 ml

    ATC: N05AX13

    Manufacturer: Pharmascience International Ltd. Universal Farma, S.L.

  • The medicine is used for the maintenance treatment of schizophrenia symptoms in stable adult patients who have previously been treated with paliperidone or risperidone. It helps to alleviate disease symptoms and prevent their recurrence.

    Form: suspension for injection prolonged release in prefilled syringe

    Active substance Dosage
    paliperidone 150 mg/1.5 ml

    ATC: N05AX13

    Manufacturer: Pharmascience International Ltd. Universal Farma, S.L.

  • The medicinal product is used for the maintenance treatment of schizophrenia symptoms in stable adult patients who have previously been treated with paliperidone or risperidone. It helps to alleviate symptoms of the disease and prevent their recurrence.

    Form: suspension for injection prolonged release in prefilled syringe

    Active substance Dosage
    paliperidone 100 mg or 150 mg

    ATC: N05AX13

    Manufacturer: Pharmascience International Ltd. Universal Farma, S.L.

  • The medicine is used for the maintenance treatment of schizophrenia symptoms in adult patients whose symptoms are already stabilized. It helps to relieve the symptoms of the disease and prevent their recurrence.

    Form: suspension for injection prolonged release in prefilled syringe

    Active substance Dosage
    paliperidone 75 mg/0.75 ml

    ATC: N05AX13

    Manufacturer: STADA Arzneimittel AG

  • The medicine is used for the maintenance treatment of schizophrenia symptoms in adult patients whose symptoms are already stabilized. It helps to alleviate the symptoms of the disease and prevent their recurrence.

    Form: suspension for injection prolonged release in prefilled syringe

    Active substance Dosage
    paliperidone 100 mg/ml

    ATC: N05AX13

    Manufacturer: STADA Arzneimittel AG

  • The medicine is used for the maintenance treatment of schizophrenia symptoms in adult patients whose symptoms are already stabilized and who have previously been treated with paliperidone or risperidone.

    Form: suspension for injection prolonged release in prefilled syringe

    Active substance Dosage
    paliperidone 150 mg/1.5 ml

    ATC: N05AX13

    Manufacturer: STADA Arzneimittel AG

  • The medicine is used for the maintenance treatment of schizophrenia symptoms in adult patients whose symptoms are already stabilized and who have previously been treated with paliperidone or risperidone.

    Form: suspension for injection prolonged release in prefilled syringe

    Active substance Dosage
    paliperidone 100 mg/ml or 150 mg/1.5 ml

    ATC: N05AX13

    Manufacturer: STADA Arzneimittel AG

  • The medicine is used for the maintenance treatment of schizophrenia symptoms in stable adult patients who have previously been treated with paliperidone or risperidone. It helps to alleviate symptoms of the disease and prevent their recurrence.

    Form: suspension for injection prolonged release in prefilled syringe

    Active substance Dosage
    paliperidone 25 mg

    ATC: N05AX13

    Manufacturer: Pharmascience International Ltd. Universal Farma, S.L.

  • The medicine is used for the maintenance treatment of schizophrenia symptoms in stable adult patients who have previously been treated with paliperidone or risperidone. It helps to alleviate symptoms of the disease and prevent their recurrence.

    Form: suspension for injection prolonged release in prefilled syringe

    Active substance Dosage
    paliperidone 50 mg

    ATC: N05AX13

    Manufacturer: Pharmascience International Ltd. Universal Farma, S.L.

  • The medicine is used for the maintenance treatment of schizophrenia symptoms in stable adult patients who have previously been treated with paliperidone or risperidone. It helps to alleviate symptoms of the disease and prevent their recurrence.

    Form: suspension for injection prolonged release in prefilled syringe

    Active substance Dosage
    paliperidone 75 mg

    ATC: N05AX13

    Manufacturer: Pharmascience International Ltd. Universal Farma, S.L.

  • The medicinal product is used for the maintenance treatment of symptoms of schizophrenia in stable adult patients who have previously been treated with paliperidone or risperidone.

    Form: suspension for injection prolonged release in prefilled syringe

    Active substance Dosage
    paliperidone 100 mg

    ATC: N05AX13

    Manufacturer: Pharmascience International Ltd. Universal Farma, S.L.

  • The medicinal product is used for the maintenance treatment of schizophrenia symptoms in stable adult patients who have previously been treated with paliperidone or risperidone.

    Form: suspension for injection prolonged release in prefilled syringe

    Active substance Dosage
    paliperidone 150 mg

    ATC: N05AX13

    Manufacturer: Pharmascience International Ltd. Universal Farma, S.L.

  • The medicine is used for the maintenance treatment of schizophrenia symptoms in stable adult patients who have previously been treated with paliperidone or risperidone. It helps to relieve symptoms of the disease and prevent their recurrence.

    Form: suspension for injection prolonged release in prefilled syringe

    Active substance Dosage
    paliperidone 100 mg or 150 mg

    ATC: N05AX13

    Manufacturer: Pharmascience International Ltd. Universal Farma, S.L.